
201 - 500 employees
Founded 1998
𧬠Biotechnology
π Pharmaceuticals
π° $4.1M Post-IPO Equity - Zealand Pharma on 2025-06
Biotechnology β’ Pharmaceuticals
Zealand Pharma is an international biotechnology company headquartered in Denmark with operations in Boston, USA. It discovers, designs, and develops peptide-based and small-molecule therapeutics focused on transforming metabolic health β particularly obesity β and addressing rare diseases such as congenital hyperinsulinism and short bowel syndrome, as well as chronic inflammatory conditions. Zealand maintains a clinical-stage pipeline of peptide analogs and receptor agonists (e. g. , amylin analogs, GLP/GIP agonists, glucagon analogs) and partners with larger pharma companies to advance programs.
π May 25
Associate Director managing third-party logistics vendors for external engagements at Zealand Pharma. Focus on operational excellence, compliance, and enhancing stakeholder experiences.
πΊπΈ United States β Remote
π΅ $190k - $240k / year
π° $4.1M Post-IPO Equity - Zealand Pharma on 2025-06
β° Full Time
π Senior
π Director